Sources

13 Total Sources

Eli Lilly Buys AtaiBeckley for $2.8 Billion as Target Stock Jumps 33%

Left43%

Center43%

Right14%

Eli Lilly to Acquire AtaiBeckley for $2.8 Billion; AtaiBeckley Stock Jumps 33%

The Wall Street Journal5h ago

Eli Lilly to Buy Psychedelic Firm AtaiBeckley for Initial $2.8 Billion - WSJ

The Economic Times3h ago

Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal - The Economic Times

Yahoo Finance5h ago

ATAI Stock Soars On Eli Lilly's $2.8B Buyout – Why Are CMPS Shares Rising Too?

Lilly makes up to $3.8B psychedelics play in AtaiBeckley takeover - BioSpace

Financial Times9h ago

Eli Lilly buys psychedelic biotech backed by Peter Thiel

Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal - AOL

Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal | Reuters

Psychedelic drugmaker AtaiBeckley shares soar 66% on Eli Lilly buyout talks

Instagram5h ago

Eli Lilly is expanding heavily into neuroscience with a deal valued at $2.8 billion upfront to acquire AtaiBeckley. The deal could reach up to $3.8 billion if milestones are met. Read more

tickeron.com5h ago

Why Is AtaiBeckley (ATAI) Stock Up +31.72% Today?

Stocktwits8h ago

ATAI Stock Soars On Eli Lilly's $2.8B Buyout – Why Are CMPS Shares Rising Too?

TradingView9h ago

ATAI Stock Soars On Eli Lilly's $2.8B Buyout – Why Are CMPS Shares Rising Too? — TradingView News